Deirdre M A O'Connor1,2, Siobhan Scarlett3,4, Céline De Looze3,4, Aisling M O'Halloran3,4, Eamon Laird3,4, Anne M Molloy4, Robert Clarke5, Christine A McGarrigle3,4, Rose Anne Kenny3,4,6. 1. The Irish Longitudinal Study on Ageing, Trinity College Dublin, Dublin, Ireland. oconnd14@tcd.ie. 2. School of Medicine, Trinity College Dublin, Dublin, Ireland. oconnd14@tcd.ie. 3. The Irish Longitudinal Study on Ageing, Trinity College Dublin, Dublin, Ireland. 4. School of Medicine, Trinity College Dublin, Dublin, Ireland. 5. Nuffield Department of Population Health, University of Oxford, Oxford, UK. 6. Mercer's Institute for Successful Ageing, St. James's Hospital, Dublin, Ireland.
Abstract
OBJECTIVE: To examine associations of plasma folate concentrations and risk of global and domain-specific cognitive decline in older people. METHODS: Data of 3140 participants from The Irish Longitudinal Study on Ageing (TILDA), a nationally-representative cohort of adults aged ≥50 years were used over 8-year follow-up. Biannual cognitive assessments included the Mini-Mental State Examination (MMSE), verbal fluency and immediate and delayed word recall tests (Waves 1-5) and the Montreal Cognitive Assessment, (MoCA) (Waves 1 and 3). Plasma folate concentrations were measured in stored blood collected at baseline. Mixed effects Poisson and linear regression determined associations between baseline folate concentrations and cognition. RESULTS: In multivariable-adjusted models of those aged ≥50 years at baseline, low folate at baseline (<11.2 nmol/L) was associated with higher proportions of MMSE errors (incidence rate ratio [IRR] = 1.10; 95% confidence interval [CI] (1.00, 1.21), lowest vs. highest quintile) over 8 years. Plasma folate <21.8 nmol/L predicted declines in episodic memory for immediate (beta [β] = -0.26; 95% CI (-0.48, -0.03), β = -0.29; 95% CI (-0.50, 0.08) and β = -0.29; (-0.50, -0.08), for lowest three vs. highest quintile) and delayed recall (β = -0.20; 95% CI (-0.38, -0.01), β = -0.18; 95% CI (-0.37, -0.01) and β = -0.19; (-0.36, -0.01) lowest three vs. highest quintile). There were no significant associations in a subsample aged ≥65 years. CONCLUSION: In those aged ≥50 years, lower concentrations of folate may have differential relationships with cognitive domains. Folate <11.2 nmol/L predicted a decline in global cognitive function, while <21.8 nmol/L predicted poorer episodic memory. Low folate was associated with accelerated decline in cognitive function and is an important marker for cognitive decline among older people.
OBJECTIVE: To examine associations of plasma folate concentrations and risk of global and domain-specific cognitive decline in older people. METHODS: Data of 3140 participants from The Irish Longitudinal Study on Ageing (TILDA), a nationally-representative cohort of adults aged ≥50 years were used over 8-year follow-up. Biannual cognitive assessments included the Mini-Mental State Examination (MMSE), verbal fluency and immediate and delayed word recall tests (Waves 1-5) and the Montreal Cognitive Assessment, (MoCA) (Waves 1 and 3). Plasma folate concentrations were measured in stored blood collected at baseline. Mixed effects Poisson and linear regression determined associations between baseline folate concentrations and cognition. RESULTS: In multivariable-adjusted models of those aged ≥50 years at baseline, low folate at baseline (<11.2 nmol/L) was associated with higher proportions of MMSE errors (incidence rate ratio [IRR] = 1.10; 95% confidence interval [CI] (1.00, 1.21), lowest vs. highest quintile) over 8 years. Plasma folate <21.8 nmol/L predicted declines in episodic memory for immediate (beta [β] = -0.26; 95% CI (-0.48, -0.03), β = -0.29; 95% CI (-0.50, 0.08) and β = -0.29; (-0.50, -0.08), for lowest three vs. highest quintile) and delayed recall (β = -0.20; 95% CI (-0.38, -0.01), β = -0.18; 95% CI (-0.37, -0.01) and β = -0.19; (-0.36, -0.01) lowest three vs. highest quintile). There were no significant associations in a subsample aged ≥65 years. CONCLUSION: In those aged ≥50 years, lower concentrations of folate may have differential relationships with cognitive domains. Folate <11.2 nmol/L predicted a decline in global cognitive function, while <21.8 nmol/L predicted poorer episodic memory. Low folate was associated with accelerated decline in cognitive function and is an important marker for cognitive decline among older people.
Authors: Oliver M Shannon; Blossom C M Stephan; Antoneta Granic; Marleen Lentjes; Shabina Hayat; Angela Mulligan; Carol Brayne; Kay-Tee Khaw; Rafe Bundy; Sarah Aldred; Michael Hornberger; Stella-Maria Paddick; Graciela Muniz-Tererra; Anne-Marie Minihane; John C Mathers; Mario Siervo Journal: Am J Clin Nutr Date: 2019-10-01 Impact factor: 7.045
Authors: Marisa I Ramos; Lindsay H Allen; Dan M Mungas; William J Jagust; Mary N Haan; Ralph Green; Joshua W Miller Journal: Am J Clin Nutr Date: 2005-12 Impact factor: 7.045
Authors: A David Smith; Stephen M Smith; Celeste A de Jager; Philippa Whitbread; Carole Johnston; Grzegorz Agacinski; Abderrahim Oulhaj; Kevin M Bradley; Robin Jacoby; Helga Refsum Journal: PLoS One Date: 2010-09-08 Impact factor: 3.240
Authors: Irene Pusceddu; Markus Herrmann; Susanne H Kirsch; Christian Werner; Ulrich Hübner; Marion Bodis; Ulrich Laufs; Thomas Widmann; Stefan Wagenpfeil; Jürgen Geisel; Wolfgang Herrmann Journal: Eur J Nutr Date: 2016-07-05 Impact factor: 5.614
Authors: Michelle Luciano; Janie Corley; Simon R Cox; Maria C Valdés Hernández; Leone C A Craig; David Alexander Dickie; Sherif Karama; Geraldine M McNeill; Mark E Bastin; Joanna M Wardlaw; Ian J Deary Journal: Neurology Date: 2017-01-04 Impact factor: 9.910